Operating companyPharmaceuticalsListed: OKUR

OnKure Therapeutics, Inc.

Boulder, CO

$159.4M

sold in all offerings

OnKure Therapeutics, Inc. is a corporation based in Boulder, CO in the Pharmaceuticals industry group. From January 8, 2018 to October 21, 2024 it filed 4 private fundraising filings for 4 offerings and reported $159 million sold in all. It is a listed company (OKUR).

Updated November 11, 2026 · newest filing Oct 21, 2024

Amount sold

$159.4M

All offerings, newest filing of each

Offered

$236.8M

Total amount sought

Offerings

4

4 filings with amendments

Newest offering

$65.0M

Sold, first filed Oct 21, 2024

Investors

20

In the newest offering

Min. investment

-

In the newest offering

Facts

Type
Corporation
Place
Boulder, CO
Industry group
Pharmaceuticals
Listed
OKUR
First filing
January 8, 2018
Newest filing
October 21, 2024
Exemptions
506(b)
Other names
Reneo Pharmaceuticals, Inc.

Amount sold by year

Each offering in the year of its first filing, at its newest amount sold

Amount sold by year

Offerings

4 offerings, newest first, each at its newest filing

First filedAmount soldOfferedInvestorsMin. investmentExemptionsSecurities
Oct 21, 2024$65.0M$65.0M20-506(b)Equity
Dec 21, 2020$47.4M$94.8M15-506(b)Equity
May 14, 2019$25.0M$25.0M9-506(b)Equity
Jan 8, 2018$22.0M$52.0M16-506(b)Equity

Filing history

4 filings, newest first. An amendment updates an earlier offering.

FiledKindAmount soldOfferedInvestors
Oct 21, 2024New offering$65.0M$65.0M20
Dec 21, 2020New offering$47.4M$94.8M15
May 14, 2019New offering$25.0M$25.0M9
Jan 8, 2018New offering$22.0M$52.0M16

Related pages

Questions and answers

How much has OnKure Therapeutics, Inc. raised in private offerings?

$159 million sold in 4 private offerings reported from Jan 8, 2018 to Oct 21, 2024, counting each offering once at its newest filing.

When did OnKure Therapeutics, Inc. last file about a private offering?

October 21, 2024. Its newest offering reported $65 million sold of $65 million offered to 20 investors.

Which exemption does OnKure Therapeutics, Inc. use?

506(b). Rule 506(b) does not allow public advertising.

Is OnKure Therapeutics, Inc. a listed company?

Yes, it is listed as OKUR.

These are notices that issuers file about their own private offerings, not verified results. Amounts are as stated in the filing. Official public data from private fundraising filings, updated daily. Amount sold is what the issuer had sold when it filed; the offered amount is the total it wants to raise.

More: Private Fundraising · Stock Screener · Industries

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.
LinkedInLinkedInXXYouTubeYouTube